Boston Beer Price Target Lowered to $194.31 as Analysts Maintain Hold Consensus
Wall Street analysts have lowered their average 12-month price target for Boston Beer Company, Inc. (SAM) to $194.31, down from a previous expectation of $196.75. The revised target reflects estimates from 13 analysts, whose individual forecasts range between $153 and $295 per share.
Despite the reduction, the updated figure offers roughly 8% potential upside compared to the stock's closing price on October 15. Overall Wall Street sentiment remains conservative, with the consensus rating holding at Hold across 15 covering analysts. Among those tracked, 12 recommend holding the stock, while one issues a Buy rating and two recommend Sell.
Investors will keep an eye on upcoming financial results and beverage sales volume to determine if operational growth can lift shares toward analyst projections. Boston Beer shares were trading at $179.20, up 0.60% on the day.
Key points
- The average 12-month price target for Boston Beer Company was lowered from $196.75 to $194.31.
- Price target estimates from 13 analysts range between $153 and $295 per share.
- The updated price target implies about 8% potential upside from the October 15 closing price.
- Wall Street maintains a consensus Hold rating, with 12 Holds, 1 Buy, and 2 Sells among 15 analysts.
- Boston Beer shares traded at $179.20, reflecting a 0.60% daily gain.
Written by our AI from expert market sources across the web. It can contain mistakes: check the facts before acting on them. Write-ups powered by the free AI API at FreeTheAI.org
How we writeDisclaimerQuestions and answers
What is the average price target for Boston Beer stock?
The average 12-month price target for Boston Beer Company is $194.31, with analyst predictions ranging from $153 to $295 per share.
What is the analyst consensus rating for Boston Beer Company?
The consensus rating is Hold across 15 covering analysts, comprising 1 Buy, 12 Holds, and 2 Sells.
How much upside does the new price target imply for Boston Beer?
The updated price target of $194.31 implies approximately 8% upside from the stock's October 15 closing price.